Inventor · disambiguated record
Klaus Erb
Also filed as: ERB KLAUS
11 granted patents·3 pending applications·21 citations·filing 1998–2024
83Inventor score
Files withABLYNX NV6BOEHRINGER INGELHEIM INT4MALAGHAN INST OF MEDICAL RES2LURGI AG1METALLGESELLSCHAFT AG1
Top patents by PatentIndex Score
14 records- 0194US11208476B2Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 28, 2021·12 cites·12 claims
- 0288US11840566B2Methods of treating asthma with polypeptides targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 12, 2023·1 cites·18 claims
- 0374US12492248B2Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Dec 9, 2025·0 cites·17 claims
- 0474US12384840B2Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLPABLYNX NV·Filed 2021·Granted Aug 12, 2025·0 cites·16 claims
- 0571US12453749B2Recombinant rhabdovirus encoding for CCL21BOEHRINGER INGELHEIM INT·Filed 2023·Granted Oct 28, 2025·0 cites·15 claims
- 0671US2025057900A1Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion proteinBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0767US2021188965A1Polypeptides comprising immunoglobulin single variable domains targeting il-13 and tslpABLYNX NV·Filed 2020·Application pending·0 cites
- 0863US12171795B2Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion proteinBOEHRINGER INGELHEIM INT·Filed 2021·Granted Dec 24, 2024·0 cites·15 claims
- 0961US6534678B1Process for producing tartaric acid from a raw material containing potassium hydrogentartrateMETALLGESELLSCHAFT AG·Filed 1999·Granted Mar 18, 2003·8 cites·6 claims
- 1060US11707495B2Recombinant rhabdovirus encoding for CCL21BOEHRINGER INGELHEIM INT·Filed 2020·Granted Jul 25, 2023·0 cites·34 claims
- 1156US12509522B2Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40LABLYNX NV·Filed 2021·Granted Dec 30, 2025·0 cites·20 claims
- 1241US7311837B2Process for the continuous recovery of free tartaric acid from raw materials containing potassium hydrogentartrateLURGI AG·Filed 2004·Granted Dec 25, 2007·0 cites·12 claims
- 1337US2003138436A1Method of using a vaccineMALAGHAN INST OF MEDICAL RES·Filed 2002·Application pending·0 cites
- 1411US6569436B1Method of using a vaccineMALAGHAN INST OF MEDICAL RES·Filed 1998·Granted May 27, 2003·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Klaus Erb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →